Erstlinienbehandlung mit PD-1-Antikörper
Crossref DOI link: https://doi.org/10.1007/s15036-021-2304-2
Published Online: 2021-02-24
Published Print: 2021-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2021-02-01
Version of Record valid from 2021-02-01
Article History
First Online: 24 February 2021